Drug ID: | NPD6781 |
Drug Name: | Epirubicin |
Molecular Formula: | C27H29NO11 |
Canonical SMILES: | OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](N)[C@H]([C@@H](O2)C)O)c2c(C1)c(O)c1c(c2O)C(=O)c2c(C1=O)cccc2OC |
Standard InCHI: | InChI=1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22-,27-/m0/s1 |
Standard InCHIKey: | AOJJSUZBOXZQNB-VTZDEGQISA-N |
Max Developmental Stage: | Approved |
Max Developmental Stage Source: | ChEMBL |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
Molecular Weight | 543.17 |
ALogP | -4.4188 |
MLogP | 3.11 |
XLogP | -1.679 |
HDA | 9 |
HBD | 6 |
Rotatable Bonds | 13 |
TPSA | 206.07 |
RO5 Violation | 1 |